NCT00571935View on ClinicalTrials.gov

Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

insulin aspart

DRUG

soluble human insulin

Trial Locations (5)

15-274

Novo Nordisk Investigational Site, Bialystok

44-100

Novo Nordisk Investigational Site, Gliwice

25-734

Novo Nordisk Investigational Site, Kielce

30-663

Novo Nordisk Investigational Site, Krakow

01-184

Novo Nordisk Investigational Site, Warsaw

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY